Search Results

There are 22694 results for: content related to: Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study

  1. You have free access to this content
    Bile salt–phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent


    Volume 50, Issue 1, July 2009, Pages: 143–154, Walee Chamulitrat, Jürgen Burhenne, Tobias Rehlen, Anita Pathil and Wolfgang Stremmel

    Version of Record online : 16 MAR 2009, DOI: 10.1002/hep.22955

  2. Abstracts of papers submitted to the american association for the study of liver diseases


    Volume 18, Issue S7, October 1993, Pages: 57A–346A,

    Version of Record online : 12 DEC 2005, DOI: 10.1002/hep.1840180703

  3. You have free access to this content
    Ursodeoxycholic acid attenuates colonic epithelial secretory function

    The Journal of Physiology

    Volume 591, Issue 9, May 2013, Pages: 2307–2318, Orlaith B. Kelly, Magdalena S. Mroz, Joseph B. J. Ward, Carolina Colliva, Michael Scharl, Roberto Pellicciari, John F. Gilmer, Padraic G. Fallon, Alan F. Hofmann, Aldo Roda, Frank E. Murray and Stephen J. Keely

    Version of Record online : 10 APR 2013, DOI: 10.1113/jphysiol.2013.252544

  4. You have free access to this content
    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 8, August 1999, Pages: 979–995, Trauner and Graziadei

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00596.x

  5. You have free access to this content
    UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation

    International Journal of Cancer

    Volume 130, Issue 12, 15 June 2012, Pages: 2771–2782, S. Krishna-Subramanian, M.L. Hanski, C. Loddenkemper, B. Choudhary, G. Pagès, M. Zeitz and C. Hanski

    Version of Record online : 30 AUG 2011, DOI: 10.1002/ijc.26336

  6. You have free access to this content
    Ursodeoxycholic acid — adverse effects and drug interactions

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 963–972, W. Hempfling, K. Dilger and U. Beuers

    Version of Record online : 14 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01792.x

  7. You have free access to this content
    Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 316–329, Maria C. Estiú, Maria J. Monte, Laura Rivas, Maria Moirón, Laura Gomez-Rodriguez, Tomas Rodriguez-Bravo, Jose J.G. Marin and Rocio I.R. Macias

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12480

  8. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro

    Journal of Digestive Diseases

    Volume 15, Issue 12, December 2014, Pages: 684–693, Lei Zhu, Lu Juan Shan, Yue Jian Liu, Dan Chen, Xiao Guang Xiao and Yan Li

    Version of Record online : 30 DEC 2014, DOI: 10.1111/1751-2980.12191

  9. Abstract of Papers Submitted to the American Association of the Study of Liver Disease


    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  10. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor


    Volume 67, Issue 12, December 2012, Pages: 1501–1510, M. A. M. Willart, M. van Nimwegen, A. Grefhorst, H. Hammad, L. Moons, H. C. Hoogsteden, B. N. Lambrecht and A. KleinJan

    Version of Record online : 25 SEP 2012, DOI: 10.1111/all.12019

  11. You have free access to this content
    Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat


    Volume 52, Issue 2, August 2010, Pages: 667–677, Carlos M. Rodríguez-Ortigosa, Jesús M. Banales, Israel Olivas, Iker Uriarte, José J.G. Marín, Fernando J. Corrales, Juan F. Medina and Jesús Prieto

    Version of Record online : 8 APR 2010, DOI: 10.1002/hep.23709

  12. You have free access to this content
    Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling

    British Journal of Pharmacology

    Volume 171, Issue 22, November 2014, Pages: 5113–5126, Anita Pathil, Jan Mueller, Johannes M Ludwig, Jiliang Wang, Arne Warth, Walee Chamulitrat and Wolfgang Stremmel

    Version of Record online : 5 SEP 2014, DOI: 10.1111/bph.12837

  13. Abstracts


    Volume 14, Issue S4, October 1991, Pages: S48–S290,

    Version of Record online : 8 DEC 2005, DOI: 10.1002/hep.1840140713

  14. You have full text access to this Open Access content
    Chemoprevention of N-Methylnitrosourea-induced Colon Carcinogenesis by Ursodeoxycholic Acid-5-aminosalicylic Acid Conjugate in F344 Rats

    Japanese Journal of Cancer Research

    Volume 93, Issue 2, February 2002, Pages: 143–150, Tomio Narisawa, Yoko Fukaura, Naomi Takeba and Keiko Nakai

    Version of Record online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2002.tb01252.x

  15. American association for the study of liver diseases


    Volume 16, Issue S4, October 1992, Pages: 1A–292A,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840160702

  16. You have free access to this content
    Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited


    Volume 36, Issue 3, September 2002, Pages: 525–531, Gustav Paumgartner and Ulrich Beuers

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.36088

  17. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy

    Journal of Gastroenterology and Hepatology


    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1996.tb01388.x

  18. You have full text access to this OnlineOpen article
    Ursodeoxycholic acid treatment in a rat model of cancer cachexia

    Journal of Cachexia, Sarcopenia and Muscle

    Volume 3, Issue 1, March 2012, Pages: 31–36, Anika Tschirner, Stephan von Haehling, Sandra Palus, Wolfram Doehner, Stefan D. Anker and Jochen Springer

    Version of Record online : 21 OCT 2011, DOI: 10.1007/s13539-011-0044-4

  19. You have free access to this content
    Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis


    Volume 29, Issue 1, January 1999, Pages: 21–26, Tousif Pasha, Jenny Heathcote, Sherine Gabriel, Karen Cauch-Dudek, Roberta Jorgensen, Terry Therneau, E. Rolland Dickson and Keith D. Lindor

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290116

  20. You have free access to this content
    Poster Session 1: Pathogenesis and Mechanisms; PBC/PSC and Other Cholestatic Disease


    Volume 62, Issue S1, October 2015, Pages: 498A–530A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28214